Stockscreener 앱 받기
0.2938
8.81%
0.0238
시장 영업 전:
.31
0.0162
+5.51%
전일 마감가:
$0.27
열려 있는:
$0.2679
하루 거래량:
4.50M
Relative Volume:
1.35
시가총액:
$13.83M
수익:
-
순이익/손실:
$-16.26M
주가수익비율:
-0.2487
EPS:
-1.1814
순현금흐름:
$-13.50M
1주 성능:
+0.27%
1개월 성능:
-11.77%
6개월 성능:
-86.21%
1년 성능:
-93.29%
1일 변동 폭
$0.2585
$0.298
1주일 범위
$0.2453
$0.30
52주 변동 폭
$0.1853
$4.4308
인텐시티 테라퓨틱스 Stock (INTS) Company Profile
명칭
Intensity Therapeutics Inc
전화
203-221-7381
주소
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
INTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.2938 | 12.43M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
인텐시티 테라퓨틱스 주식(INTS)의 최신 뉴스
Analyzing recovery setups for Intensity Therapeutics Inc. investors [Weekly Gains Report]Free Safe Capital Growth Stock Tips - Newser
Intensity (INTS) Q2 Net Loss Drops 50% - AOL.com
Analyzing recovery setups for Intensity Therapeutics Inc. investorsHigh Accuracy Trade Setup Identification - Newser
Intensity Therapeutics Amends Bylaws for Quorum Change - MSN
Sentiment analysis tools applied to Intensity Therapeutics Inc.Free Triple Digit Return Stock Predictions - Newser
Can momentum traders help lift Intensity Therapeutics Inc.New Guidance & Real-Time Market Trend Scan - Newser
Brookline Capital upgrades Intensity Therapeutics stock rating to Buy By Investing.com - Investing.com Australia
Using data filters to optimize entry into Intensity Therapeutics Inc.Value Investing Summary and Earnings Outlook - Newser
Intensity Therapeutics regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Nigeria
Intensity Therapeutics regains compliance with Nasdaq listing requirements - Investing.com
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - WV News
How Intensity Therapeutics Inc. stock performs during market volatilityFree Stock Market Watch With Alerts - Newser
Using Python tools to backtest Intensity Therapeutics Inc. strategiesSwing Trade Entry and Exit Point Analysis - Newser
Why Intensity Therapeutics Inc. stock attracts strong analyst attentionBuy and Hold Position Summary Review - Newser
How to recover losses in Intensity Therapeutics Inc. stockAI Driven Swing Trade Forecasting Insight - Newser
Multi factor analysis applied to Intensity Therapeutics Inc.Intraday Movement Recap and Chart Summary - Newser
Is Intensity Therapeutics Inc. still worth holding after the dipStock Portfolio Risk and Return Analysis - Newser
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Morningstar
Is Intensity Therapeutics Inc. meeting your algorithmic filter criteriaTechnical Insight Guide for Safer Trades - Newser
Shelton biotech raises millions for novel cancer treatment - Hartford Business Journal
why intensity therapeutics inc. stock attracts strong analyst attentionAI-Based Reversal Point Prediction Signal - Newser
Intensity Therapeutics Raises $6.6 Million in July Offering - TipRanks
Intensity Therapeutics Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Intensity Therapeutics raises $6.6M from ATM stock sales in July - TipRanks
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025 - Citizen Tribune
Biotech Intensity Therapeutics Secures $6.6M Funding at Premium Price, Extends Operations Through 2026 - Stock Titan
Is Intensity Therapeutics Inc. stock overvalued or undervaluedBuild wealth faster with consistent investment plans - Jammu Links News
What analysts say about Intensity Therapeutics Inc. stockUnlock superior stock analysis tools - Jammu Links News
What are analysts’ price targets for Intensity Therapeutics Inc. in the next 12 monthsFree Trading Psychology Coaching - Jammu Links News
Is Intensity Therapeutics Inc. a good long term investmentFree Stock Selection - Jammu Links News
How does Intensity Therapeutics Inc. generate profit in a changing economyMaximize your returns with expert insights - Jammu Links News
Is it the right time to buy Intensity Therapeutics Inc. stockTremendous growth opportunities - Jammu Links News
How strong is Intensity Therapeutics Inc. company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News
What catalysts could drive Intensity Therapeutics Inc. stock higher in 2025Consistent high-yield stocks - Jammu Links News
What drives Intensity Therapeutics Inc. stock priceRobust investment performance - Jammu Links News
How does Intensity Therapeutics Inc. compare to its industry peersDiscover dynamic stocks ready to soar - Jammu Links News
What is the dividend policy of Intensity Therapeutics Inc. stockSuperior stock growth - Jammu Links News
What are the latest earnings results for Intensity Therapeutics Inc.Invest smarter with data-backed insights - jammulinksnews.com
인텐시티 테라퓨틱스 (INTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
3.06%
자본화:
|
볼륨(24시간):